Anticancer and structure-activity relationship evaluation of 3-(naphthalen-2-yl)-N,5-diphenyl-pyrazoline-1-carbothioamide analogs of chalcone

Add time:07/13/2019    Source:sciencedirect.com

To identify new potent chemotherapeutic agents, we synthesized compounds with 3-(naphthalen-2-yl)-N,5-diphenyl-pyrazoline-1-carbothioamide (NDPC) skeletons and evaluated their cytotoxicities using a clonogenic long-term survival assay. Their half-maximal cell growth inhibitory concentrations ranged from a few hundred nanomolars to a few micromolars. Further biological experiments including flow cytometry and western blotting analysis were performed with the derivative showing the best cytotoxicity. To identify a target protein of the selected compound, an in vitro kinase assay was carried out, which revealed that aurora kinases A and B were inhibited by the test compound, and this was confirmed using western blot analysis. The molecular binding mode between the selected compound and the kinases was elucidated using in silico docking. The structural conditions required for good cytotoxicity were identified based on the quantitative relationships between the physicochemical properties of the derivatives and their cytotoxicities.

We also recommend Trading Suppliers and Manufacturers of 3-(naphthalen-1-yl)-2-thioxo-1,3-thiazolidin-4-one (cas 23517-78-4). Pls Click Website Link as below: cas 23517-78-4 suppliers

Prev:Synthesis, characterization and aggregation properties of non-peripherally (1R,2R)-1,2-di(naphthalen-1-yl)ethane-1,2-diol substituted optically active zinc phthalocyanine and its catalytic application in enantioselective ethylation of aldehydes
Next:Synthesis, photophysical and theoretical studies of substituted ethyl 4-(3-(naphthalen-1-yl)-1-phenyl-4,5-dihydro-1H-pyrazol-5-yl)benzoate)